NO941123D0 - Neuromedin-B-reseptor-antagonister - Google Patents

Neuromedin-B-reseptor-antagonister

Info

Publication number: NO941123D0
Authority: NO; Norway
Prior art keywords: neuromedin; receptor antagonists; nal; cys; receptor
Prior art date: 1992-07-27

Application number

NO941123A

Other languages

English (en)

Norwegian (no)

Other versions

NO941123L (no

Inventor

David Howard Coy

John E Taylor

Original Assignee

Univ Tulane

Biomeasure Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-27

Filing date

1994-03-25

Publication date

1994-03-25

1993-06-17 Priority claimed from US08/078,419 external-priority patent/US5462926A/en

1994-03-25 Application filed by Univ Tulane, Biomeasure Inc filed Critical Univ Tulane

1994-03-25 Publication of NO941123L publication Critical patent/NO941123L/no

1994-03-25 Publication of NO941123D0 publication Critical patent/NO941123D0/no

Links

108010073466 Bombesin Receptors Proteins 0.000 title abstract 2
102000052872 Neuromedin B receptors Human genes 0.000 title abstract 2
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1
YPFNACALNKVZNK-MFNIMNRCSA-N (2s)-2-[(2-aminoacetyl)amino]-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3r)-1-[[2-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1- Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CN)[C@@H](C)O)C1=CC=CC=C1 YPFNACALNKVZNK-MFNIMNRCSA-N 0.000 abstract 1
102100038819 Neuromedin-B Human genes 0.000 abstract 1
101800001639 Neuromedin-B Proteins 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Biophysics (AREA)
Immunology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO941123A 1992-07-27 1994-03-25 Neuromedin-B-reseptor-antagonister NO941123D0 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US91953792A	1992-07-27	1992-07-27
US08/078,419 US5462926A (en)	1992-07-27	1993-06-17	Neuromedin B receptor antagonists which demonstrate selectivity
PCT/US1993/007036 WO1994002163A1 (en)	1992-07-27	1993-07-27	Neuromedin b receptor antagonists

Publications (2)

Publication Number	Publication Date
NO941123L NO941123L (no)	1994-03-25
NO941123D0 true NO941123D0 (no)	1994-03-25

Family

ID=25442276

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO941123A NO941123D0 (no)	1992-07-27	1994-03-25	Neuromedin-B-reseptor-antagonister

Country Status (10)

Country	Link
EP (1)	EP0606463B1 (de)
JP (1)	JP3553062B2 (de)
AT (1)	ATE206307T1 (de)
AU (1)	AU672426B2 (de)
CA (1)	CA2118588A1 (de)
DE (1)	DE69330868T2 (de)
DK (1)	DK0606463T3 (de)
ES (1)	ES2162822T3 (de)
NO (1)	NO941123D0 (de)
WO (1)	WO1994002163A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5569741A (en) *	1992-07-27	1996-10-29	Biomeasure, Inc.	Cyclic octapeptide neuromedin B receptor antagonists
JPH09328499A (ja) *	1996-02-20	1997-12-22	American Cyanamid Co	純粋なソマトスタチンアンタゴニストおよびその使用方法
US5846934A (en) *	1996-02-20	1998-12-08	American Cyanamid Company	Pure somatostatin antagonist and methods of use thereof
KR100558131B1 (ko)	1999-03-29	2006-03-10	더 프록터 앤드 갬블 캄파니	멜라노코르틴 수용체 리간드를 함유하는 약제학적 조성물및 멜라노코르틴 수용체 리간드를 함유하는 약제의제조방법
US7862825B2 (en)	2007-02-21	2011-01-04	Mladen Vranic	Method of controlling tight blood glucose by somatostatin receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH085913B2 (ja) *	1985-09-12	1996-01-24	ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド	治療用ソマトスタチン同族体
JP2809403B2 (ja) *	1987-07-07	1998-10-08	ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド	治療用ソマトスタチンアナログ化合物
CA1339083C (en) *	1987-11-13	1997-07-29	Steven R. Jefferies	Bone repair material and delayed drug delivery system
US5073541A (en) *	1987-11-18	1991-12-17	Administrators Of The Tulane Educational Fund	Treatment of small cell lung cancer with somatostatin analogs
KR0173119B1 (ko) *	1989-04-26	1999-02-01	닐 에이. 밴스로우	선형 소마토스타틴 유사체
WO1991004040A1 (en) *	1989-09-15	1991-04-04	Biomeasure, Inc.	Treatment of colon cancer
KR920702854A (ko) *	1989-12-08	1992-10-28	원본미기재	제6위치에 트레오닌을 가지고 있는 소마토 스타틴의 옥타펩티드 유사물

1993
- 1993-07-27 DK DK93918408T patent/DK0606463T3/da active
- 1993-07-27 AT AT93918408T patent/ATE206307T1/de not_active IP Right Cessation
- 1993-07-27 WO PCT/US1993/007036 patent/WO1994002163A1/en not_active Ceased
- 1993-07-27 AU AU47871/93A patent/AU672426B2/en not_active Ceased
- 1993-07-27 JP JP50476294A patent/JP3553062B2/ja not_active Expired - Fee Related
- 1993-07-27 ES ES93918408T patent/ES2162822T3/es not_active Expired - Lifetime
- 1993-07-27 DE DE69330868T patent/DE69330868T2/de not_active Expired - Fee Related
- 1993-07-27 EP EP93918408A patent/EP0606463B1/de not_active Expired - Lifetime
- 1993-07-27 CA CA002118588A patent/CA2118588A1/en not_active Abandoned
1994
- 1994-03-25 NO NO941123A patent/NO941123D0/no unknown

Also Published As

Publication number	Publication date
JP3553062B2 (ja)	2004-08-11
WO1994002163A1 (en)	1994-02-03
DE69330868D1 (de)	2001-11-08
JPH06511495A (ja)	1994-12-22
EP0606463B1 (de)	2001-10-04
ATE206307T1 (de)	2001-10-15
CA2118588A1 (en)	1994-02-03
AU672426B2 (en)	1996-10-03
DE69330868T2 (de)	2002-04-25
NO941123L (no)	1994-03-25
EP0606463A4 (en)	1997-09-24
AU4787193A (en)	1994-02-14
ES2162822T3 (es)	2002-01-16
EP0606463A1 (de)	1994-07-20
DK0606463T3 (da)	2001-12-03

Similar Documents

Publication	Publication Date	Title
FI884486L (fi)	1988-09-29	Katalysatorer, foerfaranden foer framstaellning daerav samt polymeriseringsfoerfaranden vari dessa katalysatorer anvaends.
DE68915162D1 (de)	1994-06-09	Nadelloses einweg-injektionssystem.
FI892351A0 (fi)	1989-05-16	Foerkalibrerade, elektrokemiska givare foer engaongsbruk.
PT1091975E (pt)	2006-05-31	Nova ciclosporina com um perfil de actividade melhorado
DE3872059D1 (de)	1992-07-23	Verfahren und vorrichtungen, um duftstoffe zu verteilen.
DE68916423D1 (de)	1994-07-28	Enzymatisch verstärkter, piezoelektrischer, spezifischer bindungstest.
ES554046A0 (es)	1987-03-16	Un metodo para analizar el adn de un individuo.
DE3680012D1 (de)	1991-08-08	Undurchlaessige, unter waerme klebende sperrschicht.
FI852965A0 (fi)	1985-07-31	Avskrapningsanordning samt foerfarande, daer det anvaendes foerspaennt avskrapningsbett.
NO902629L (no)	1990-06-13	Hellingskompensator for hurtigkjoerende kjoeretoey, saerlig skinnekjoeretoey.
FI892259A0 (fi)	1989-05-10	Hissikorien jakelujärjestelmä, jolla on painotettu suhteellinen järjestelmävaste
DE3788771D1 (de)	1994-02-24	NH3-Einspritzregler.
ATE75778T1 (de)	1992-05-15	Immunosuppressionsfaktor.
ATE110074T1 (de)	1994-09-15	Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.
DE3781140D1 (de)	1992-09-17	Plattenfoermige, ionenempfindliche elektrode.
DE3687532D1 (de)	1993-03-04	Zyklische hexapeptid-lhrh-antagonisten.
NO941123D0 (no)	1994-03-25	Neuromedin-B-reseptor-antagonister
NO870694D0 (no)	1987-02-20	Fremgangsmaate for bestemmelse av mikrobekonsentrasjoner med en smelteagarmetode, samt deri anvendte skaaler.
DE68914617D1 (de)	1994-05-19	Nachweisvorrichtung für Kathodenlumineszenzanalyse.
MX9204870A (es)	1993-04-01	Heteroaril poliaminas sinteticas como antagonistas neurotransmisores de aminoacido excitadores.
ES2022699B3 (es)	1991-12-01	Retenedor de asiento de valvula.
ATE457317T1 (de)	2010-02-15	Chemokine rezeptor
NO891432L (no)	1989-10-09	Elektrostatisk, flytende fremkaller.
FI872557A7 (fi)	1987-06-08	Transportoer, speciellt foer pao en haengare upphaengda foeremaol.
CO4230141A1 (es)	1995-10-19	Acc-sintasa de crucifera y sus usos